Devyser secures a major tender worth SEK 61.8 M in Udine, Italy
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
News | June 26, 2025
Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant research
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of Devyser HLA Loss, a next-generation sequencing (NGS) assay designed exclusively to empower researchers...
Find out more
.png)
.png)
.png)
.png)